3Chopt Investment Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
4,350
-484
-10% -$131K 0.27% 85
2025
Q4
$1.21M Sell
4,834
-171
-3% -$45.4K 0.27% 81
2025
Q3
$1.44M Sell
5,005
-126
-2% -$33.8K 0.33% 75
2025
Q2
$1.35M Sell
5,131
-144
-3% -$35.1K 0.32% 71
2025
Q1
$1.23M Buy
+5,275
New +$1.28M 0.32% 77
2024
Q3
Sell
-6,478
Closed -$1.32M 130
2024
Q2
$1.32M Buy
+6,478
New +$1.32M 0.4% 60
2024
Q1
Sell
-6,803
Closed -$1.55M 118
2023
Q4
$1.55M Buy
+6,803
New +$1.43M 0.57% 47
2023
Q3
Sell
-7,984
Closed -$1.66M 95
2023
Q2
$1.66M Sell
7,984
-1,458
-15% -$283K 0.83% 37
2023
Q1
$1.86M Buy
9,442
+24
+0.3% +$4.94K 0.99% 34
2022
Q4
$1.91M Buy
+9,418
New +$1.84M 1.04% 33

Other funds holding LH

3Chopt Investment Partners's LH Position: Q1 2026 in Review

3Chopt Investment Partners reduced its Labcorp (LH) stake by 10% in Q1 2026, selling an estimated $131K and leaving 4,350 shares worth $1.16M. The position accounts for 0.27% of the portfolio, ranked #85.

3Chopt Investment Partners first reported a position in LH in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.91M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • 3Chopt Investment Partners held 4,350 shares of Labcorp worth $1.16M as of Q1 2026.
  • 3Chopt Investment Partners sold 484 Labcorp shares in Q1 2026, an estimated $131K.
  • Labcorp made up 0.27% of 3Chopt Investment Partners's portfolio in Q1 2026, its #85 holding.
  • 3Chopt Investment Partners first reported a position in Labcorp in Q4 2022 and has held it in 10 quarters since.
  • 3Chopt Investment Partners's Labcorp position peaked at $1.91M in Q4 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on 3Chopt Investment Partners's 13F filing for Q1 2026, filed 23 Apr 2026.